Comparison between Emcure Pharmaceuticals IPO and Sanstar IPO.
Emcure Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sanstar IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Emcure Pharmaceuticals IPO is up to ₹1,952.03 Cr whereas the issue size of the Sanstar IPO is up to ₹510.15 Cr. The final issue price of Emcure Pharmaceuticals IPO is ₹1,008.00 per share and of Sanstar IPO is ₹95.00 per share.
| Emcure Pharmaceuticals IPO | Sanstar IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹960.00 per share | ₹90.00 per share |
| Issue Price (Upper) | ₹1,008.00 per share | ₹95.00 per share |
| Issue Price (Final) | ₹1,008.00 per share | ₹95.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹90.00 per share | |
| Market Lot Size | 14 shares | 150 shares |
| Fresh Issue Size | 79,46,231 shares | 4,18,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹800.58 Cr | up to ₹397.10 Cr |
| OFS Issue Size | 1,14,28,839 shares | 1,19,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,151.45 Cr | up to ₹113.05 Cr |
| Issue Size Total | 1,93,75,070 shares | 5,37,00,000 shares |
| Issue Size Total (Amount) | up to ₹1,952.03 Cr | up to ₹510.15 Cr |
Emcure Pharmaceuticals IPO opens on Jul 03, 2024, while Sanstar IPO opens on Jul 19, 2024. The closing date of Emcure Pharmaceuticals IPO and Sanstar IPO is Jul 05, 2024, and Jul 23, 2024, respectively.
| Emcure Pharmaceuticals IPO | Sanstar IPO | |
|---|---|---|
| Anchor Bid Date | Jul 02, 2024 | Jul 18, 2024 |
| Issue Open | Jul 03, 2024 | Jul 19, 2024 |
| Issue Close | Jul 05, 2024 | Jul 23, 2024 |
| Basis Of Allotment (Tentative) | Jul 08, 2024 | Jul 24, 2024 |
| Initiation of Refunds (Tentative) | Jul 09, 2024 | Jul 25, 2024 |
| Credit of Share (Tentative) | Jul 09, 2024 | Jul 25, 2024 |
| Listing date (Tentative) | Jul 10, 2024 | Jul 26, 2024 |
| Anchor Lockin End date 1 | Aug 07, 2024 | Aug 23, 2024 |
| Anchor Lockin End date 2 | Oct 06, 2024 | Oct 22, 2024 |
Emcure Pharmaceuticals IPO P/E ratio is 34.55, as compared to Sanstar IPO P/E ratio of 19.98.
| Emcure Pharmaceuticals IPO | Sanstar IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.21 | 99.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 78.08 | 70.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 34.55 | 19.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹19029.89 Cr. | ₹1731.32 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 16.90% | 30.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.37% | 24.43% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.67 | 0.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹29.17 | ₹4.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.87% | 30.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Emcure Pharmaceuticals IPO Retail Individual Investors (RII) are offered 67,43,160 shares while in Sanstar IPO retail investors are offered 67,43,160 shares. Qualified Institutional Buyers (QIB) are offered 38,53,234 shares in Emcure Pharmaceuticals IPO and 1,07,40,000 shares in Sanstar IPO.
| Emcure Pharmaceuticals IPO | Sanstar IPO | |
|---|---|---|
| Anchor Investor Reservation | 57,79,850 shares | 1,61,10,000 shares |
| Market Maker Reservation | ||
| QIB | 38,53,234 shares | 1,07,40,000 shares |
| NII | 28,89,926 shares | 80,55,000 shares |
| RII | 67,43,160 shares | 1,87,95,000 shares |
| Employee | 1,08,900 shares | |
| Others | ||
| Total | 1,93,75,070 shares | 5,37,00,000 shares |
Emcure Pharmaceuticals IPO subscribed 67.87x in total, whereas Sanstar IPO subscribed 82.99x.
| Emcure Pharmaceuticals IPO | Sanstar IPO | |
|---|---|---|
| QIB (times) | 191.24x | 145.68x |
| NII (times) | 49.32x | 136.49x |
| Big NII (times) | 54.90x | 149.44x |
| Small NII (times) | 38.16x | 110.61x |
| RII (times) | 7.36x | 24.23x |
| Employee (times) | 8.81x | |
| Other (times) | ||
| Total (times) | 67.87x | 82.99x |
